Shareholders Equity: The sum of preferred and common equity items.
Immuneering Corporation (IMRX) had Shareholders Equity of $218.48M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-56.02M |
|
-- |
|
-- |
|
$59.38M |
|
$-59.38M |
|
$3.35M |
|
$-56.02M |
|
$-56.02M |
|
$-56.02M |
|
$-56.02M |
|
$-56.02M |
|
$-56.02M |
|
$-59.38M |
|
$-58.83M |
|
44.01M |
|
44.01M |
|
$-1.27 |
|
$-1.27 |
|
| Balance Sheet Financials | |
$176.25M |
|
$0.94M |
|
$55.74M |
|
$231.99M |
|
$10.07M |
|
-- |
|
$3.43M |
|
$13.50M |
|
$218.48M |
|
$211.47M |
|
|
Shareholders Equity |
$218.48M |
64.65M |
|
| Cash Flow Statement Financials | |
$-45.34M |
|
$-88.74M |
|
$226.58M |
|
$36.14M |
|
$128.65M |
|
$92.50M |
|
$6.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.50 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-45.49M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-25.64% |
|
-26.49% |
|
-24.15% |
|
-25.64% |
|
$3.38 |
|
$-1.03 |
|
$-1.03 |
|